TheProfitWatch

CGEM - Cullinan Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
8.66 1.12 (12.93%) 0.0 (0.0%) 0.01 (0.1%) -0.08 (-0.81%) 0.37 (4.27%) 1.05 (12.03%) --- 0.37 (4.27%)

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
Diluted EPS:
Basic P/E:
Diluted P/E:
RSI(14) 1m:
71.43
VWAP:
9.78
RVol:

Events

Period Kind Movement Occurred At

Related News